We performed a prospective interventional study to evaluate correlations between hearing thresholds determined by pure-tone audiometry (PTA) and auditory steady-state response (ASSR) testing in two types of patients with hearing loss and a control group of persons with normal hearing. The study was conducted on 240 ears-80 ears with conductive hearing loss, 80 ears with sensorineural hearing loss, and 80 normal-hearing ears. We found that mean threshold differences between PTA results and ASSR testing at different frequencies did not exceed 15 dB in any group. Using Pearson correlation coefficient calculations, we determined that the two responses correlated better in patients with sensorineural hearing loss than in those with conductive hearing loss. We conclude that measuring ASSRs can be an excellent complement to other diagnostic methods in determining hearing thresholds.
Introduction
Pure-tone audiometry (PTA) is the gold standard for the evaluation of hearing levels. Audiometers are used to make quantitative measurements of pure-tone air-and bone-conduction thresholds. However, it is not possible to obtain reliable thresholds with PTA in all patients. Small children and patients with developmental or neurologic delays are examples of the difficult-to-test population. In addition, if a patient's hearing is being tested by PTA alone for a medicolegal reason, malingering might be possible.
Hearing loss in infants should be identified and treated early to prevent delays in speech and language development. Six months of age is a critical time with respect to their future performance in these areas. 1 All children need a comprehensive audiologic evaluation. This should include an accurate estimation of hearing thresholds in case a child with hearing loss requires a hearing aid or even cochlear implantation. 2 Auditory brainstem response (ABR) testing can be used as an objective alternative for acquiring pure-tone audiograms in infants and children who are not suited to behavioral-observation audiometry. 3, 4 ABR testing conducted with click stimuli is associated with a high degree of reproducibility and stability of the waveform. However, frequency specificity in ABR testing is poor, and therefore its use in identifying threshold levels in the lower audiometric range is poor. 5 Another limitation of the use of ABR testing is in the evaluation of severe to profound hearing loss. ABR testing is inadequate for determining thresholds greater than 90 dB HL. 6, 7 This limitation can make hearing losses that exceed the maximum output difficult or impossible to quantify. Tone-burst ABR testing has not been established in everyday clinical practice because it has an unfamiliar waveform morphology, especially in very young children. Also, tone-burst ABR testing is a time-consuming process that elicits no responses in cases of severe and profound hearing loss. 8 Auditory steady-state response (ASSR) testing is a newly developed measurement of auditory evoked potentials that can be used to objectively predict frequency-specific hearing thresholds. In ASSR testing, pure-tone sounds are used as the stimulus. Pure-tone sound is modulated in the amplitude domain and frequency domain. Modulation of a pure-tone sound stimulus narrows the spectral splatter, resulting in stimulation of a very restricted and narrow area of the basilar membrane. 9 This means that a more frequency-specific hearing threshold can be elicited by ASSR testing than by ABR testing. If the rate of modulation is higher than 60 Hz, the neural activity is recorded from the brainstem.
Responses from the brainstem are not affected by the mental state of the patient, and therefore they can be recorded even in sedated infants and children. 9 The responses are analyzed by a sophisticated, objective, statistically based mathematical detection algorithm to provide hearing thresholds at four given frequencies. 10 In addition, ASSR testing allows for stimulation at high intensity levels of 120 dB HL, whereas ABR testing cannot differentiate between severe and profound hearing losses. 7, 11, 12 The ability to detect differences in these significant hearing-loss categories is important. For example, differentiating a 75-dB hearing loss from a 95-dB hearing loss may have an impact on decisions such as whether to fit a traditional hearing aid in a child with a 75-dB sensorineural hearing loss (SNHL) or to consider cochlear implantation options for a child with a 95-dB SNHL. 13 Finally, the response detection in the frequency domain based on statistical tests assures us that the ASSRs are detected objectively. Detection is not based on subjective visual examinations of the waveforms or response patterns. 14 During the past few years, several studies have evaluated the clinical application of ASSR testing as an objective audiometric method. Reports have demonstrated significant correlations between PTA and ASSR test results in various age groups and in patients with different levels of hearing loss. 10 Despite good correlations between PTA and ASSR values, there has been significant variability among study results, as reported differences in PTA and ASSR values have ranged from 4 to 34 dB. 2 In this article, we describe our study to evaluate correlations between the hearing thresholds determined by PTA and ASSR testing in patients with hearing loss and in persons with normal hearing.
Patients and methods
This prospective study was conducted during the 17-month period from September 2012 through January 2014 in the Department of Otorhinolaryngology at Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PT. BDS PGIMS) in Rohtak, India.
Our study population was made up of 120 participants aged 18 to 80 years, who were recruited into three groups of 40 depending on their hearing status:
• conductive hearing loss: 19 men and 21 women (mean age: 30.4 ± 10.1 yr) with conductive hearing loss (CHL), defined as an air-conduction threshold ranging from 26 to 60 dB with normal bone-conduction thresholds;
• SNHL: 21 men and 19 women (mean age: 34.3 ± 16.6 yr) with SNHL, defined as air-and bone-conduction thresholds greater than 25 dB; and
• normal hearing: a control group of 26 men and 14 women (mean age: 26.4 ± 5.7 yr) with normal hearing, defined as an air-conduction threshold of 25 dB or less.
We did not include in our study any individuals younger than 18 years. Also ineligible were patients who exhibited:
• a mixed hearing loss; • a difference of more than 40 dB in air-conduction thresholds between their two ears on PTA;
• any skin disease of the external ear, scalp, or face;
• any congenital anomalies of the auricle or external auditory meatus;
• an unreliable response on PTA; and • an actively discharging ear.
Hearing status was determined by tuning-fork testing, PTA, and ASSR testing, all conducted in both ears on the same day for each participant. Pure-tone thresholds by air conduction were established for frequencies ranging from 0.25 to 4.0 kHz.
The SNHL group was further divided into two subgroups: those patients with mild to moderate SNHL (air-conduction thresholds ranging from 26 to 55 dB on PTA) and those with moderately severe to profound SNHL (air-conduction thresholds of >55 dB).
PTA stimuli. PTA was conducted with an ALPS AD 2000+ audiometer (ALPS; New Delhi). For evaluation and statistical purposes, thresholds were measured at 0.5, 1.0, 2.0, and 4.0 kHz. ASSR stimuli. ASSR measurements were recorded on a Universal Smart Box Junior two-channel device (Intelligent Hearing Systems; Miami) in a sound-attenuated room. Participants were tested while they were awake and in a relaxed supine position. Registration electrodes were placed over both mastoid bones at the hairline and on the low forehead. Air-conducted stimuli were presented via inserted earphones. Test frequencies of 0.5, 1.0, 2.0, and 4.0 kHz were used as ASSR carrier stimuli.
The four carrier frequencies were delivered simultaneously to both ears. These frequencies were modulated with respect to amplitude and frequency. A 100% amplitude modulation was used, and 20% frequency a controlled coMparison of auditorY steadY-state responses and pure-tone audioMetrY in patients with hearing loss modulation was combined with the amplitude modulation. Modulation frequency was different for each carrier frequency: 77 Hz for 0.5 kHz, 85 Hz for 1.0 kHz, 93 Hz for 2.0 kHz, and 101 Hz for 4.0 kHz. The ASSR threshold was defined as the lowest intensity at which a significant response could be detected; a nonsignificant response was defined as one that was 10 dB below this level.
Statistical analysis. After the PTA and ASSR measurements, statistical analysis was performed with the Statistical Package for the Social Sciences software (v. 17.0). Continuous variables were presented as a mean with standard deviation, and categorical variables were presented as absolute numbers and percentages. The comparison of normally distributed continuous variables between PTA and ASSR results was performed with the Student t test. Within groups, the Pearson correlation coefficient (r value) was calculated between the PTA and ASSR results measured at 0.5, 1.0, 2.0, and 4.0 kHz. Instances in which ASSR testing did not elicit any response were excluded from the final statistical analysis. A p value of <0.05 was considered to represent statistical significance.
Ethical considerations. This study protocol was approved by the PT. BDS PGIMS ethics committee, and all participants provided informed consent.
Results
Mean PTA and ASSR thresholds at each frequency in the three groups are shown in table 1. Mean threshold differences were statistically significant at 0.5 and 1.0 kHz in the CHL group and at 4.0 kHz in the SNHL group. In the control group, the mean threshold differences were not statistically significant at any frequency; we attributed this finding to chance.
The mean difference in the four-frequency (0.5, 1.0, 2.0, and 4.0 kHz) pure-tone average and the ASSR threshold average was 10 ± 8 dB in the CHL group, 8 ± 7 dB in the SNHL group, and 6 ± 5 dB in the control group. The difference between the CHL group and the control group (p < 0.001) and between the SNHL group and the control group (p = 0.039) were statistically significant.
The correlation coefficient values between the PTA and ASSR results at each frequency in the three groups are shown in table 2. We found a good correlation between PTA and ASSR measurements in the SNHL and CHL groups. The correlation was best at 1.0 kHz in both groups; the correlation in the control group was poor.
The four-frequency pure-tone average and ASSR threshold average were calculated for each ear. We found that in the CHL group, ASSR thresholds overestimated PTA thresholds in 61% of the ears, underestimated it in 35%, and matched it in 4%. In the SNHL group, the corresponding figures were 42, 50, and 8%, and in the control group, they were 59, 39, and 2%. In the CHL group, 84% of ASSR threshold values were within 20 dB, 76% were within 15 dB, and 63% were within 10 dB of the threshold values estimated by PTA. In the SNHL group, the corresponding figures were 93, 83, and 70%, and in the control group they were 96, 93, and 83%.
Mean PTA and ASSR thresholds at each frequency in the two SNHL subgroups are summarized in table 3. Pearson r values between the PTA and ASSR results at each frequency in two SNHL subgroups are shown in table 4. In the mild to moderate SNHL group, the correlation was best at 2.0 kHz, while in the moderately severe to profound group, the correlation was best at 1.0 kHz and weakest at 0.5 kHz.
Discussion
In our study, the smallest difference between mean PTA and ASSR thresholds was seen at 1.0 kHz (8 ± 7 dB) in the control group. Ozdek et al also reported that the difference between mean PTA and ASSR thresholds was smallest in their control group at 1.0 kHz. 2 In their hearing-impaired group, they found that the difference between mean PTA and ASSR thresholds was largest at 4.0 kHz, which is consistent with our findings in our SNHL group. In their study, the difference between mean PTA and ASSR thresholds at each frequency was no more than 15 dB in both their hearing-impaired and control groups. We also found no difference of more than 15 dB at each frequency in all three of our groups. Moreover, Ozdek et al found that the difference between mean PTA and ASSR thresholds at each frequency was smaller in their hearing-impaired patients than in their controls. However, we found that the difference was smaller in our control group than in our CHL and SNHL groups.
A study by D'haenens et al found that patients with moderate SNHL had lower mean threshold differences than their controls did, but there was no significant difference between the controls and patients with mild SNHL. 15 But in our study, the mean threshold differences at each frequency in our control group were lower than those of both subgroups of SNHL patients. Among patients with CHL in the study by D'haenens et al, the difference between mean PTA and ASSR thresholds was smallest at 4.0 kHz, which is consistent with the findings of our CHL group. In our study, mean threshold differences at each frequency in the control group were lower than those of our CHL group, but D'haenens et al reported that the mean threshold differences were higher at all frequencies except 2.0 kHz in their control group than in their CHL group. They also reported that mean threshold differences in their combined SNHL group were lower at all frequencies except 2.0 kHz than those of their controls, which is not consistent with our findings.
We found that ASSR results poorly correlated with PTA values in our control group. Similar findings were observed in the study by Ozdek et al. 2 They reported that the r values between the PTA and ASSR results in their control group were 0.165, 0.352, 0.146, and 0.472 at 0.5, 1.0, 2.0, and 4.0 kHz, respectively. In their hearing-impaired group, the corresponding r values were 0.920, 0.931, 0.953, and 0.774. In our study, we also found a strong correlation between PTA and ASSR values in our SNHL group, with r values of 0.76, 0.82, 0.79, and 0.68 for the four frequencies.
In our study, the r values for the differences between the PTA and ASSR results in the CHL group were 0.640, 0.664, 0.624, and 0.655 at 0.5, 1.0, 2.0, and 4.0 kHz, respectively. D'haenens et al also reported good correlation between PTA and ASSR results in their CHL group: Their corresponding r values were 0.76, 0.89, 0.81, and 0.82 at the four frequencies. 15 Ahn et al reported that ASSR results were highly correlated with PTA results in patients with mild to moderate (r = 0.91) and severe to profound (r = 0.91) hearing loss. 16 Results were less strongly correlated in patients with normal hearing (r = 0.62). They suggested that ASSR testing might be less suitable for assessing patients with normal hearing. Our study also found a poor correlation in the control group.
Likewise, Komazec et al reported that correlation coefficients with respect to the level of hearing loss were the lowest in persons with normal hearing (r = 0.64) and in patients with only a slight hearing loss (r = 0.63). 10 They were greatest in patients with moderate hearing loss (r = 0.93). In our study, the mild to moderate SNHL group exhibited good correlation between PTA and ASSR results at all four frequencies. In the moderately severe to profound SNHL group, the correlation was best at 1 .0 kHz and weakest at 0.5 kHz.
Some studies have found a significantly lower level of correlation at 0.5 kHz than at other frequencies.
Komazec et al reported that this difference was most often found in people with normal hearing thresholds in whom the variation between hearing thresholds determined by PTA and ASSR testing was the highest. 10 Lins and Picton suggested that ASSR results should be interpreted with caution at 0.5 kHz because low-frequency-evoked responses are characterized by a greater degree of intrinsic jitter attributable to neural asynchrony. 17 This could make it more difficult to determine threshold levels for low-frequency stimuli than for high-frequency stimuli. Lower levels of correlation at 0.5 kHz might also be attributable to noise floor. In our study, the correlation was poor at 0.5 kHz in our control group, but the correlation was good in our CHL (r = 0.640) and SNHL (r = 0.766) groups.
The degree of hearing loss seems to play an important role in the correlation between PTA and ASSR thresholds. Because of physiologic recruitment, the two thresholds are closer to each other in patients with SNHL than in persons with normal hearing. 18 The study by Ahn et al was conducted in 105 participants. 16 The authors found that in their hearing-impaired group, the results of the two tests were highly correlated, whereas in their the control group, the correlation was somewhat weaker. The smaller threshold differences found in hearing-impaired patients might reflect an abnormal increment in the response amplitude at above-threshold intensities because of the presence of recruitment for the damage to the outer hair cells. 2 The findings of our study support the findings of these other reports. We observed a high degree of correlation between the two tests in patients with hearing loss. The ASSR amplitude was higher in patients with SNHL than in our controls, which we attributed to loudness recruitment. This resulted in a better ASSR signal-to-noise ratio and therefore a more easily detected threshold level. 19 To optimize the gap between PTA and ASSR thresholds, examinations must be carried out while patients are asleep or totally relaxed in a sound-proof room to reduce the background electrical noise caused by transient movements and electromyogenic potentials. 8 To be used as a standard diagnostic clinical instrument, ASSR systems must establish normative air-conduction as well as bone-conduction ASSR thresholds, not only for persons with normal hearing and those with SNHL, but also for patients with CHL and mixed hearing loss. 15 Because it is still relatively new, ASSR testing requires further experience and study data on large numbers of patients so that we might understand all its intricacies. Many factors, including (1) the type of modulation, (2) the number of sweeps acquired during response analysis, (3) electrode montage, and (4) modulation rate, can affect ASSR results, and these factors have not yet been fully elucidated. Improvements in the methodologic aspects of ASSR testing should encourage its routine use in clinical practice. 2 In summary, our study found that ASSR testing correlated with PTA results better in patients with SNHL than in those with CHL. Although the mean threshold differences were smaller in our control group, ASSR testing correlated poorly with PTA in this group. We conclude that ASSR testing can be an excellent complement to other diagnostic methods to serve as a valuable tool in the determination of hearing thresholds.
